Munich Re : The stock needs a breather
Entry price | Target | Stop-loss | Potential |
---|
€229.3 |
€216.5 |
€235 |
+5.58% |
---|
Shares in Muenchener Rueckversicherung AG could enter into a technical downturn after the gains that were recorded over the last trading sessions.
Summary● The company usually posts poor financials for mid or long term investments.
Strengths● The company is one of the best yield companies with high dividend expectations.
● For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
● The stock is in a well-established, long-term rising trend above the technical support level at 205.3 EUR
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 239.
● The stock is close to a major daily resistance at EUR 230.3, which should be gotten rid of so as to gain new appreciation potential.
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The group usually releases earnings worse than estimated.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.